Literature DB >> 21172596

Predictors of coronary artery visualization in Kawasaki disease.

Renee Margossian1, Minmin Lu, L LuAnn Minich, Timothy J Bradley, Meryl S Cohen, Jennifer S Li, Beth F Printz, Girish S Shirali, Lynn A Sleeper, Jane W Newburger, Steven D Colan.   

Abstract

BACKGROUND: Echocardiography is the imaging modality of choice for the evaluation of coronary artery (CA) abnormalities in Kawasaki disease. Small series have established high specificity and sensitivity for detecting abnormalities, yet visualization rates of individual CA segments and factors associated with success are unknown.
METHODS: In the Pediatric Heart Network's randomized trial of primary steroid treatment for Kawasaki disease, echocardiograms were interpreted locally and by a core laboratory. Univariate and multivariate predictors of CA visualization by the local lab as determined by the core lab were explored, and agreement of CA size measured locally and by the core lab was assessed.
RESULTS: A total of 589 echocardiograms from 199 patients were obtained over 27 months. Visualization rates for the left main, proximal and distal left anterior descending, and proximal right CAs ranged from 91% to 98% but were lower for the distal right (65%), circumflex (86%), and posterior descending (54%) CAs. For the distal right and circumflex CAs, visualization rates improved over the course of the study (P<.05). In multivariate analysis, local center, CA segment, and time from study start to echocardiography were independent predictors of visualization (all P values<.001). For segments for which visualization rates varied by center, higher percentage visualization was associated with larger center volume (P=.001). Routine sedation use was also associated with higher visualization rates.
CONCLUSIONS: Successful CA visualization in Kawasaki disease is associated with the segment being evaluated and is influenced by center volume and sedation use. Increased visualization rates over time suggest a learning curve and underscore the value of core lab oversight in pediatric multicenter trials.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21172596      PMCID: PMC3022385          DOI: 10.1016/j.echo.2010.10.015

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  20 in total

1.  Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. A plea for core laboratories.

Authors:  L H Baur; J J Schipperheyn; E A van der Velde; E E van der Wall; J H Reiber; R J van der Geest; P R van Dijkman; J G Gerritsen; B L van Eck-Smit; P J Voogd; A V Bruschke
Journal:  Int J Card Imaging       Date:  1996-12

2.  Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction.

Authors:  T Hole; J E Otterstad; M St John Sutton; G Frøland; I Holme; T Skjaerpe
Journal:  Eur J Echocardiogr       Date:  2002-12

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Safety and efficacy of chloral hydrate sedation in children undergoing echocardiography.

Authors:  K L Napoli; C G Ingall; G R Martin
Journal:  J Pediatr       Date:  1996-08       Impact factor: 4.406

5.  Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in heart failure trial (Val-HeFT).

Authors:  Maylene Wong; Lidia Staszewsky; Alberto Volpi; Roberto Latini; Simona Barlera; Christer Höglund
Journal:  J Am Soc Echocardiogr       Date:  2002-04       Impact factor: 5.251

Review 6.  Kawasaki disease. With particular emphasis on arterial lesions.

Authors:  S Naoe; K Takahashi; H Masuda; N Tanaka
Journal:  Acta Pathol Jpn       Date:  1991-11

7.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

8.  Chloral hydrate side effects in young children: causes and management.

Authors:  M Lipshitz; B L Marino; S T Sanders
Journal:  Heart Lung       Date:  1993 Sep-Oct       Impact factor: 2.210

9.  Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease.

Authors:  T E Capannari; S R Daniels; R A Meyer; D C Schwartz; S Kaplan
Journal:  J Am Coll Cardiol       Date:  1986-02       Impact factor: 24.094

10.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

View more
  8 in total

Review 1.  Acquired coronary disease in children: the role of multimodality imaging.

Authors:  Phalla Ou; Shelby Kutty; Diala Khraiche; Daniel Sidi; Damien Bonnet
Journal:  Pediatr Radiol       Date:  2012-09-13

2.  Ascending Aorta Elastography After Kawasaki Disease Compared to Systemic Hypertension.

Authors:  Ian Nandlall; Roch L Maurice; Anne Fournier; Aïcha Merouani; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2015-04-29       Impact factor: 1.655

3.  Factors impacting echocardiographic imaging after the Fontan procedure: a report from the pediatric heart network fontan cross-sectional study.

Authors:  Richard V Williams; Renee Margossian; Minmin Lu; Andrew M Atz; Timothy J Bradley; Michael Jay Campbell; Steven D Colan; Dianne Gallagher; Wyman W Lai; Gail D Pearson; Ashwin Prakash; Girish Shirali; Meryl S Cohen
Journal:  Echocardiography       Date:  2013-04-25       Impact factor: 1.724

4.  Unplanned Repeat Echocardiography with Sedation in Children: Patient Risk Factors.

Authors:  Kenan W D Stern; Chen Chen; Hillel W Cohen; Joseph Mahgerefteh; Sarah A Chambers; Leo Lopez
Journal:  Pediatr Cardiol       Date:  2016-04-18       Impact factor: 1.655

5.  Intravenous Immunoglobulin Infusion Reactions in Kawasaki Disease Patients Who Undergo Sedation.

Authors:  Elizabeth Nguyen; Daniel Hershey; Gale Romanowski; Adriana Tremoulet
Journal:  J Pediatr Pharmacol Ther       Date:  2020

6.  Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.

Authors:  Shohei Ogata; Adriana H Tremoulet; Yuichiro Sato; Kayla Ueda; Chisato Shimizu; Xiaoying Sun; Sonia Jain; Laura Silverstein; Annette L Baker; Noboru Tanaka; Yoshihito Ogihara; Satoshi Ikehara; Shinichi Takatsuki; Naoko Sakamoto; Tohru Kobayashi; Shigeto Fuse; Tomoyo Matsubara; Masahiro Ishii; Tsutomu Saji; Jane W Newburger; Jane C Burns
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

Review 7.  Diagnosis of Kawasaki disease.

Authors:  Surjit Singh; Ankur Kumar Jindal; Rakesh Kumar Pilania
Journal:  Int J Rheum Dis       Date:  2017-11-13       Impact factor: 2.454

Review 8.  CMR in inflammatory vasculitis.

Authors:  Subha V Raman; Ashish Aneja; Wael N Jarjour
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-30       Impact factor: 5.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.